An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study is being done to see if Nexium I.V. can reduce and control stomach acid in
mechanically ventilated, critically ill patients in an Intensive Care Unit setting.